| Trigueros-Motos L, González-Granado JM, Cheung C, Fernández P, Sánchez-Cabo F, Dopazo A, Sinha S, Andrés V. Embryological-Origin-Dependent Differences in Hox Expression in Adult Aorta: Role in Regional Phenotypic Variability and Regulation of NF-κB Activity. Arterioscler Thromb Vasc Biol (2013) 33:1248-56 |
| Silvestre-Roig C, Fernández P, Esteban V, Pello OM, Indolfi C, Rodríguez C, Rodríguez-Calvo R, López-Maderuelo MD, Bauriedel G, Hutter R, Fuster V, Ibáñez B, Redondo JM, Martínez-González J, Andrés V. Inactivation of Nuclear Factor-Y Inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation. Arterioscler Thromb Vasc Biol (2013) 33:1036-45 |
| Aguilera-Montilla N, Chamorro S, Nieto C, Sánchez-Cabo F, Dopazo A, Fernández-Salguero PM, Rodríguez-Fernández JL, Pello OM, Andrés V, Cuenda A, Alonso B, Domínguez-Soto A, Sánchez-Ramón S, Corbi AL. Aryl hydrocarbon receptor contributes to the MEK/ERK-dependent maintenance of the immature state of human dendritic cells. Blood (2013) 121:e108-17 |
| González-Navarro H, Vinué A, Sanz MJ, Delgado M, Pozo MA, Serrano M, Burks DJ, Andrés V. Increased dosage of Ink4/Arf protects against glucose intolerance and insulin resistance associated with aging. Aging Cell (2013) 12:102-11 |
| Fuster JJ, Molina-Sánchez P, Jovaní D, Vinué A, Serrano M, Andrés V. Increased gene dosage of the Ink4/Arf locus does not attenuate atherosclerosis development in hypercholesterolaemic mice. Atherosclerosis (2012) 221:98-105 |
| Fuster JJ, González-Navarro H, Vinué A, Molina P, Andrés-Manzano MJ, Nakayama KI, Nakayama K, Díez-Juan A, Bernad A, Rodríguez C, Martínez-González J, Andrés V. Deficient p27 Phosphorylation at Serine 10 Increases Macrophage Foam Cell Formation and Aggravates Atherosclerosis Through a Proliferation-Independent Mechanism. Arterioscler Thromb Vasc Biol (2011) 31:2455-2463 |
| Pello OM, Silvestre C, De Pizzol M, Andrés V. A glimpse on the phenomenon of macrophage polarization during atherosclerosis. Immunobiology (2011) 216:1172-6 |
| Rodríguez J, Calvo F, González JM, Casar B, Andrés V, Crespo P. ERK1/2 MAP kinases promote cell cycle entry by rapid, kinase-independent disruption of retinoblastoma-lamin A complexes. J Cell Biol (2010) 191:967-79 |
| González-Navarro H, Naim Abu Nabah Y, Vinué A, Andrés-Manzano MJ, Collado M, Serrano M, Andrés V. p19(ARF) Deficiency Reduces Macrophage and Vascular Smooth Muscle Cell Apoptosis and Aggravates Atherosclerosis. J Am Coll Cardiol (2010) 55:2258-68 |
| Fuster JJ, Fernandez P, Gonzalez-Navarro H, Silvestre C, Abu Nabah YN, Andres V. Control of cell proliferation in atherosclerosis: insights from animal models and human studies. Cardiovasc Res (2010) 86:254-64 |
- Vicente Andrés García
- Group leader
- Ext.1502
Vicente Andrés obtained his PhD in Biological Sciences from the University of Barcelona (1990). During postdoctoral training at the Children's Hospital, Harvard University (1991-1994) and the St. Elizabeth's Medical Center, Tufts University (1994-1995), he led studies into the role of homeobox and MEF2 transcription factors in processes of cellular differentiation and proliferation; and it was also during this period that he developed an interest in cardiovascular research.
His career as an independent research scientist began in 1995 when he was appointed Assistant Professor of Medicine at Tufts. Since then Dr. Andrés and his group have studied vascular remodeling during atherosclerosis and post-angioplasty restenosis. After obtaining a position as a Tenured Research Scientist in the Spanish National Research Council (CSIC), Dr. Andrés returned to Spain in 1999 to establish his research group in the Institute of Biomedicine of Valencia, where he worked as a Full Professor. Since 2006, his group has been a member of the Red Temática de Investigación Cooperativa en Enfermedades Cardiovasculares (RECAVA). He joined the CNIC in September 2009.
In 2010 he was awarded the Doctor Leon Dumont Prize by the Belgian Society of Cardiology
© 2013 Centro Nacional de Investigaciones Cardiovasculares